You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

PREMPHASE 14/14 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


US Patents and Regulatory Information for PREMPHASE 14/14

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PREMPHASE 14/14

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 ⤷  Try a Trial ⤷  Try a Trial
Wyeth Pharms PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 ⤷  Try a Trial ⤷  Try a Trial
Wyeth Pharms PREMPHASE 14/14 estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-002 Nov 17, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PREMPHASE 14/14

See the table below for patents covering PREMPHASE 14/14 around the world.

Country Patent Number Title Estimated Expiration
Japan 3833292 ⤷  Try a Trial
Denmark 0628052 ⤷  Try a Trial
Spain 2179165 ⤷  Try a Trial
Philippines 24052 A METHOD OF HORMONAL TREATMENT OF PERIMENOPAUSAL,MENOPAUSAL AND POST-MENOPAUSAL DISORDERS ⤷  Try a Trial
Iceland 4385 ⤷  Try a Trial
Denmark 377084 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PREMPHASE 14/14

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0136011 SPC/GB00/025 United Kingdom ⤷  Try a Trial SPC/GB00/025: 20040802, EXPIRES: 20090801
0136011 SPC/GB97/032 United Kingdom ⤷  Try a Trial SPC/GB97/032: 20040802, EXPIRES: 20090801
0136011 97C0056 Belgium ⤷  Try a Trial PRODUCT NAME: OESTROGENES CONJUGUES + MEDROXYPROGESTERONACETAS; NAT. REGISTRATION NO/DATE: 428 IS 194 F 3 19970520; FIRST REGISTRATION: CH 52649 19940826
0136011 SPC/GB98/034 United Kingdom ⤷  Try a Trial SPC/GB98/034: 20040802, EXPIRES: 20090801
0136011 980038 Netherlands ⤷  Try a Trial 980038, 20090801, EXPIRES: 20130305
0136011 91096 Luxembourg ⤷  Try a Trial 91096, EXPIRES: 20090802
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.